Image_4_Circulating Adaptive Immune Cells Expressing the Gut Homing Marker α4β7 Integrin Are Decreased in COVID-19.tif by Tanja M. Müller (10026137)

“…</p>Conclusion<p>COVID-19 is associated with a decrease in circulating adaptive immune cells expressing the key gut homing marker α4β7 suggesting that these cells are preferentially recruited to extra-intestinal tissues independently of α4β7 or that the systemic immune response against SARS-CoV-2 is at least numerically dominated by extraintestinal, particularly pulmonary, immune cell priming.…”

Image_3_Circulating Adaptive Immune Cells Expressing the Gut Homing Marker α4β7 Integrin Are Decreased in COVID-19.tif by Tanja M. Müller (10026137)

“…</p>Conclusion<p>COVID-19 is associated with a decrease in circulating adaptive immune cells expressing the key gut homing marker α4β7 suggesting that these cells are preferentially recruited to extra-intestinal tissues independently of α4β7 or that the systemic immune response against SARS-CoV-2 is at least numerically dominated by extraintestinal, particularly pulmonary, immune cell priming.…”

Data for Figs 8A–8H, 9A–9K, 10A–10I. by Xiaohua Zhang (350570)

CD34⁺ cell populations decreased in malaria. by Carmen M. Dickinson-Copeland (824626)

Regulatory B10 cells are augmented and the level of IL-10 expression is decreased in the spleen of AD mice. by Jieqiong Li (327149)

“…<p>(A) Representative dot-plots showing the percentage of CD5⁺CD19⁺CD1d^hi B10 cells in control (n = 10) and AD mice (n = 10); (B) Bar graph depicting the percentage of CD5⁺CD19⁺CD1d^hiB10 cells in control and AD mice as analyzed by flow cytometry. …”

Frequency compensation in the feedback scheme of Fig 4a for a stepwise change in <i>k</i>₂ at background <i>k</i>₁₀ = 2048.0. by Melissa Nygård (15374507)

TMEM182 decreases OSCC cell motility. by En-Wei Hsing (154990)

Fig 10 - by Xiaolan Liu (294511)

Tacrolimus Decreases Albuminuria in Patients with IgA Nephropathy and Normal Blood Pressure: A Double-Blind Randomized Controlled Trial of Efficacy of Tacrolimus on IgA Nephropathy by Yong-Chul Kim (1637572)

“…The pre-defined secondary outcomes were better in the Tac group compared to the control group. The frequency of decrease in pcUACR and percentage change of UPCR (pcUPCR) ≥50% at 16 weeks were 65.0% (13/20) and 55.0% (11/20)in the Tac group, and 25.0% (5/20) and 15.0% (3/20), in the control group, respectively (p = 0.025 for pcUACR and p = 0.019 for pcUPCR). …”

Graphs showing the mean maximum temperature increase at the position with the highest mean temperature increase (A) and the mean temperature increase across all probes (B) for each... by Marsel Ganeyev (21453399)

Flowchart displaying the steps of the present study. by Jingtian Yang (11966345)

A Yoga Strengthening Program Designed to Minimize the Knee Adduction Moment for Women with Knee Osteoarthritis: A Proof-Of-Principle Cohort Study by Elora C. Brenneman (795723)

“…A secondary objective was to determine whether the program could improve mobility and fitness, and decrease peak KAM during gait. …”

Reduced follicles, decreased ovulation and decreased fertilization of female Meox-2-cre/Separase S1121A mutant mice. by Juan Xu (225010)

Taurolidine lock solution for catheter-related bloodstream infections in pediatric patients: A meta-analysis by Yan Sun (22436)

“…The number of catheters removed due to infection or suspected infection was not significantly different between the two groups (RR: 0.68; 95% CI:0.22, 2.10; I² = 56%; P = 0.50) (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0231110#pone.0231110.g005" target="_blank">Fig 5</a>). …”

Infection of B6 mice with wild type <i>B</i>. <i>hermsii</i> and <i>Bh</i>Δ<i>dam</i> at decreasing infectious doses of approximately 1 x 10⁵ to 10 spirochetes. by Allison E. James (2794606)

Maximum frequencies as a function of +<i>k</i>₁₀, where is the <i>k</i>₂ value in phase 2. by Melissa Nygård (15374507)

Outcome variable descriptive statistics. by Kristen S. Regenauer (13842386)

Demographic & job characteristics. by Kristen S. Regenauer (13842386)

Training feedback. by Kristen S. Regenauer (13842386)

Study flow. by Kristen S. Regenauer (13842386)